Mark G. Currie
InvestorVenture Partner at Iaso Ventures
About
Biopharma leader and pharmacologist, former President and CSO and scientific founder of Cyclerion Therapeutics and R&D leader at Ironwood. Primary inventor of linaclotide (Linzess), with numerous board and advisory roles.
Deals · 1
Sea PharmaceuticalsBoard seat
via Iaso Ventures · filed May 2026 · $1.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Iaso Ventures
Anil S. Jina
Executive in Residence at Iaso Ventures
Chandra Ramanathan
Advisor, Biotech at Iaso Ventures
John Reynders
Chief Data Scientist & Venture Partner at Iaso Ventures
Maurizio Fava
Advisor, Clinical R&D at Iaso Ventures
Michael Fenn
Venture Partner at Iaso Ventures
Noah J. Richmond
Advisor, Legal & IP at Iaso Ventures
Raymond Sanchez
Advisor, Drug Development at Iaso Ventures
Sadiqa Mahmood
Entrepreneur in Residence at Iaso Ventures